Combined synopsis and solicitation
Flawnamics Seg-Flow S3 Agilent Interface
75F40124Q00374
Food and Drug Administration, FDA Office of Acq Grant SVCS. All Other Miscellaneous Electrical Equipment and Component Manufacturing.
Response deadline
July 2, 2024 at 4:00 PM EDT
Closed 856 days ago. Posted June 29, 2024. Scheduled to archive July 3, 2024.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 2024
63 like it are open now in all other miscellaneous electrical equipment and component manufacturing
- EPP III Cables & Conduits
Defense Logistics Agency, DLA Land at Aberdeen
SolicitationNAICS 335999Anywhere in the USSPRBL1-27-R-A006Closes tomorrowNov 6 - BPA - Electrical and Electronic Components PSC 5999
Department of the Navy, NSWC Indian Head Division
Combined synopsis and solicitationSmall businessNAICS 335999Anywhere in the USN0017424SN0022Closes in 737 daysNov 11, 2028 - CONVERTER,DIGITAL T
Department of the Navy, NAVSUP Weapon Systems Support Mech
SolicitationNAICS 335999Anywhere in the USN0010427QUA06Closes todayNov 5
All 63 open in all other miscellaneous electrical equipment and component manufacturing
Description
As published on SAM.gov.
FDA Office of Product Quality and Research require an interface to integrate our previously installed Seg-Flow S3 (Flownamics) and Ultivo LC-MS (Agilent). This system must integrate communications between both instruments and automatically coordinate in-process samples. Automatic sampling must be scheduled across multiple vessels and send in-process samples to our Agilent LC-MS for real-time analysis. This interface must be compatible with Seg-Flow S3, Ultivo LC-MS, and these instruments’ corresponding software.
This interface shall include a sample interface kit (S3 Sample Dilution Module) to allow physical connection between the Seg-Flow S3 and Agilent Ultivo LC-MS via Sample Mod S3 or comparable module.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
June 29, 2024
Combined synopsis and solicitation
Due July 2, 2024 at 4:00 PM EDT. SAM.gov, notice 444efbc4c6e145348a9c54f574897111
Points of contact
- Min Jie Zengminjie.zeng@fda.hhs.gov